CHD has been described across many of the BP1-BP2 microdeletion studies, but it is not part of the defining characteristics for the 15q11.2 syndrome, likely due to its low penetrance and phenotypic heterogeneity. Here, IGFBP2 is linked to coronary artery disorder.